Nektar Therapeutics
NKTR
#5702
Rank
โ‚ฌ1.18 B
Marketcap
34,76ย โ‚ฌ
Share price
-0.79%
Change (1 day)
-35.95%
Change (1 year)

Earnings for Nektar Therapeutics (NKTR)

Earnings in 2026 (TTM): -โ‚ฌ0.14 Billion

According to Nektar Therapeutics 's latest financial reports the company's current earnings are โ‚ฌ54.58 Million. In 2025 the company made an earning of -โ‚ฌ0.14 Billion a decrease over its 2024 earnings that were of -โ‚ฌ0.11 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Nektar Therapeutics from 1994 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚ฌ0.14 Billion-5.12%
2025 -โ‚ฌ0.14 Billion30.44%
2024 -โ‚ฌ0.11 Billion-56.85%
2023 -โ‚ฌ0.25 Billion-24.31%
2022 -โ‚ฌ0.33 Billion-30.25%
2021 -โ‚ฌ0.47 Billion17.87%
2020 -โ‚ฌ0.4 Billion0.88%
2019 -โ‚ฌ0.4 Billion-164.46%
2018 โ‚ฌ0.61 B-810.61%
2017 -โ‚ฌ85.92 Million-37.06%
2016 -โ‚ฌ0.14 Billion89.22%
2015 -โ‚ฌ72.14 Million48.22%
2014 -โ‚ฌ48.68 Million-65.93%
2013 -โ‚ฌ0.15 Billion-6.81%
2012 -โ‚ฌ0.16 Billion28.95%
2011 -โ‚ฌ0.12 Billion258.8%
2010 -โ‚ฌ33.14 Million-63.94%
2009 -โ‚ฌ91.91 Million-392.45%
2008 โ‚ฌ31.42 M-211.74%
2007 -โ‚ฌ28.13 Million-79.57%
2006 -โ‚ฌ0.14 Billion-16.9%
2005 -โ‚ฌ0.17 Billion81.53%
2004 -โ‚ฌ91.26 Million54.19%
2003 -โ‚ฌ59.19 Million-33.87%
2002 -โ‚ฌ89.5 Million-9.6%
2001 -โ‚ฌ99 Million73.39%
2000 -โ‚ฌ57.1 Million108.9%
1999 -โ‚ฌ27.34 Million39.48%
1998 -โ‚ฌ19.6 Million60.02%
1997 -โ‚ฌ12.25 Million18.05%
1996 -โ‚ฌ10.38 Million31.82%
1995 -โ‚ฌ7.87 Million57.14%
1994 -โ‚ฌ5.01 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
โ‚ฌ23.43 B-17,216.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚ฌ6.17 B-4,611.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚ฌ9.19 B-6,818.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
-โ‚ฌ0.44 Billion 215.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚ฌ6.87 B-5,122.40%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚ฌ12.81 B-9,460.35%๐Ÿ‡ฌ๐Ÿ‡ง UK
Richardson Electronics
RELL
โ‚ฌ6.68 M-104.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Alkermes
ALKS
โ‚ฌ0.21 B-254.92%๐Ÿ‡ฎ๐Ÿ‡ช Ireland